Cancer Research
3 articles

Biotechnology & Genetics
Gene editing advancements promise new treatments for complex diseases
CRISPR-Cas12a2 has selectively killed cells with a cancer-causing mutation, leaving healthy cells unaffected, according to Utah State University .
Maria Flores·June 12, 2026

Cosmos & Physics
Revolution Medicines Reports Promising Pancreatic Cancer Drug Results
Patients with previously treated metastatic pancreatic cancer lived an average of 13 additional months with Revolution Medicines' new drug, daraxonrasib, more than double the survival rate of standard
Dr. Evelyn Reed·May 31, 2026

Computational Science & Software
Pfizer Shares Updated Lung Cancer Bispecifics Data at ASCO
At the ASCO Annual Meeting, updated Phase 2 data for Pfizer's bispecific antibody PF-08634404 demonstrated activity as monotherapy in first-line PD-L1-expressing non-small cell lung cancer.
Yasmin Haddad·May 31, 2026